An aggressive subtype of B-CLL is characterized by strong CD44 expression and lack of CD11c (Q71127550)
scientific article published on 01 June 1996
Language:
Current Data About An aggressive subtype of B-CLL is characterized by strong CD44 expression and lack of CD11c
(P31) (Q13442814)
(P248)
(P698) 8652389
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8652389%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, October 16, 2019

(P304) 661-669
(P248)
(P698) 8652389
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8652389%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, October 16, 2019

(P407) (Q1860)

(P433) 3
(P248)
(P698) 8652389
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8652389%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, October 16, 2019

(P478) 93
(P248)
(P698) 8652389
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8652389%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, October 16, 2019

(P577) Saturday, June 1, 1996
(P248)
(P698) 8652389
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8652389%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, October 16, 2019

(P921) (Q11829285)
(P887)

(P1433) (Q4970200)
(P248)
(P698) 8652389
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8652389%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, October 16, 2019

(P1476) "An aggressive subtype of B-CLL is characterized by strong CD44 expression and lack of CD11c" (language: en)
(P248)
(P698) 8652389
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8652389%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, October 16, 2019

(P2093) W Eistere
(P1545) 1
(P248)
(P698) 8652389
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8652389%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, October 16, 2019

W Hilbe
(P1545) 2
(P248)
(P698) 8652389
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8652389%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, October 16, 2019

R Stauder
(P1545) 3
(P248)
(P698) 8652389
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8652389%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, October 16, 2019

O Bechter
(P1545) 4
(P248)
(P698) 8652389
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8652389%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, October 16, 2019

F Fend
(P1545) 5
(P248)
(P698) 8652389
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8652389%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, October 16, 2019

J Thaler
(P1545) 6
(P248)
(P698) 8652389
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8652389%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, October 16, 2019

other details
description scientific article published on 01 June 1996

External Links
(P356) 10.1046/J.1365-2141.1996.D01-1704.X
(P698) 8652389